Well, that review sure is convenient timing for Newman. I don't rate him at all. He's been CEO since what, late 2015? And he's still blaming the ex Exec Team? What a joke!
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025